Usually, monitoring of the plasmatic prostate-specific antigen (PSA) level in the blood is used for the check-up of the health state of the prostate, and if the value is higher than 4 ng/mL, it is a possible risk factor for prostate cancer [7]. This evidence concerns the gene KLK3 and prostate cancer.